Third‐generation oncolytic herpes simplex virus inhibits the growth of liver tumors in mice

Multimodality therapies are used to manage patients with hepatocellular carcinoma (HCC), although advanced HCC is incurable. Oncolytic virus therapy is probably the next major breakthrough in cancer treatment. The third‐generation oncolytic herpes simplex virus type 1 (HSV‐1) T‐01 kills tumor cells...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Sci
Main Authors: Nakatake, Richi, Kaibori, Masaki, Nakamura, Yusuke, Tanaka, Yoshito, Matushima, Hideyuki, Okumura, Tadayoshi, Murakami, Takashi, Ino, Yasushi, Todo, Tomoki, Kon, Masanori
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5834814/
https://ncbi.nlm.nih.gov/pubmed/29288515
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13492
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados